Experimental. Legal. Transparent.
What ANOVA IRM's regulatory status means for patients
International medicines authorities rightly warn against unregulated and insufficiently tested cell therapies. ANOVA IRM has therefore summarised its regulatory status openly and in a publicly verifiable way. Our treatments are experimental, but they take place within a legally regulated framework that is supervised by the authorities.

Regenerative medicine is complex. Transparency about manufacturing, quality and regulatory status should not be.
Our commitment: to state clearly what is documented – and equally clearly what remains experimental.
Note: This newsletter provides information about the regulatory framework. It does not replace individual medical advice.
Patient Services at ANOVA Institute for Regenerative Medicine
- Located in the center of Germany, quick access by car or train from anywhere in Europe
- Simple access worldwide, less than 20 minutes from Frankfurt Airport
- Individualized therapy with state-of-the-art autologous stem cell products
- Individually planned diagnostic work-up which include world-class MRI and CT scans
- German high quality standard on safety and quality assurance
- Personal service with friendly, dedicated Patient Care Managers
- Continuous analysis of scientific data in the field of regenerative medicine